Intra-Cellular Therapies Reports Third Quarter 2015 Financial Results and Provides Corporate Update
NEW YORK, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the …